Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

First Quarter 2018 Financial Results

Genmab will report its First Quarter 2018 financial results after market close on May 8. An investor conference call to discuss the results will be held at 6PM CEST / 12PM EDT on May 8. To join the call by phone, dial one of the following numbers and ask for the Genmab conference call: +45 35 15 81 21 in Denmark, +44 (0)330 336 9411 in the UK or +1 323 794 2094 in the US. Click here to listen to the webcast. 

strategy_150x110New Strategy Progress Film 

Genmab has launched a new film about the company's strategy and progress.  The film was played for shareholders at the company's Annual General Meeting on April 10.  Click here to watch the film.  


Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members